EC
TMDX icon

Elequin Capital’s Transmedics TMDX Stock Holding History

Elequin Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133 Sell
2
-35
-95% -$2.96K ﹤0.01% 654
2026
Q1 		$3.68K Sell
37
-70
-65% -$9.13K ﹤0.01% 417
2025
Q4 		$13K Buy
+107
New +$13.4K ﹤0.01% 217
2025
Q1 		– Sell
-88
Closed -$5.49K – 628
2024
Q4 		$5.49K Buy
+88
New +$8.19K ﹤0.01% 393
2024
Q2 		– Sell
-119
Closed -$8.8K – 348
2024
Q1 		$8.8K Buy
+119
New +$9.81K ﹤0.01% 115
2023
Q3 		– Sell
-16
Closed -$1.34K – 601
2023
Q2 		$1.34K Buy
+16
New +$1.23K ﹤0.01% 467

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Elequin Capital's TMDX Position: Q2 2026 in Review

Elequin Capital reduced its Transmedics (TMDX) stake by 95% in Q2 2026, selling an estimated $2.96K and leaving 2 shares worth $133. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Elequin Capital first reported a position in TMDX in Q2 2023 and has held it in 6 quarters since. The position peaked at $13K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Elequin Capital held 2 shares of Transmedics worth $133 as of Q2 2026.
  • Elequin Capital sold 35 Transmedics shares in Q2 2026, an estimated $2.96K.
  • Transmedics made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #654 holding.
  • Elequin Capital first reported a position in Transmedics in Q2 2023 and has held it in 6 quarters since.
  • Elequin Capital's Transmedics position peaked at $13K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.